"10.1371_journal.pone.0016780","plos one","2011-02-08T00:00:00Z","Luis Alberto Garc√≠a Rodr√≠guez; Antonio Gonz√°lez-P√©rez; H√©ctor Bueno; John Hwa","Centro Espa√±ol de Investigaci√≥n Farmacoepidemiol√≥gica (CEIFE), Madrid, Spain; Departamento de Gen√≥mica Estructural, Neocodex SL, Sevilla, Spain; Department of Cardiology, Hospital General Universitario Gregorio Mara√±√≥n, Madrid, Spain; Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America","Conceived and designed the experiments: LAGR AG-P. Performed the experiments: LAGR AG-P. Analyzed the data: LAGR AG-P JH. Wrote the paper: LAGR AG-P JH HB.","I have read the journals policy and have the following conflicts: CEIFE has received unrestricted research grants from Bayer and Pfizer in the last five years. Dr. Bueno reports having received consulting fees from Almirall, Bayer, BMS, and Sanofi-Aventis, and research grants from Astra-Zeneca, BMS, and Pfizer. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.","2011","02","Luis Alberto Garc√≠a Rodr√≠guez","LAG√R√",4,TRUE,2,2,3,4,TRUE,TRUE,TRUE,1,"2",FALSE
